Tectonic Therapeutic, Inc. (TECX)

NASDAQ: TECX · Real-Time Price · USD

54.14

-0.70 (-1.28%)

At close: Jan 31, 2025, 4:00 PM

55.00

+0.86 (1.59%)

After-hours: Jan 31, 2025, 7:37 PM EST

Tectonic Therapeutic Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2014	FY 2013
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Revenue	-	-	-	-	0.14	0.14
Revenue Growth (YoY)	-	-	-	-	2.13%	-
Gross Profit	-	-	-	-	0.14	0.14
Selling, General & Admin	14	7.68	7.18	4.63	-	-
Research & Development	39.4	36.97	25.65	10.98	-	-
Operating Expenses	53.4	44.65	32.83	15.61	-	-
Operating Income	-53.4	-44.65	-32.83	-15.61	-	-
Interest Expense	-0.12	-0.15	-0.14	-0.45	-	-
Interest & Investment Income	2.66	0.58	0.15	-	-	-
Other Non Operating Income (Expenses)	-2.62	1.4	0.65	8.1	-	-
EBT Excluding Unusual Items	-53.48	-42.82	-32.18	-7.96	-	-
Other Unusual Items	-	-	-	-0.97	-	-
Pretax Income	-53.48	-42.82	-32.18	-8.93	-	-
Earnings From Continuing Operations	-	-42.82	-32.18	-8.93	-	-
Net Income	-53.48	-42.82	-32.18	-8.93	0.01	-0.01
Net Income to Common	-53.48	-42.82	-32.18	-8.93	-	-
Shares Outstanding (Basic)	15	3	3	-	-	-
Shares Outstanding (Diluted)	15	3	3	-	-	-
Shares Change (YoY)	483.46%	4.29%	-	-	-	-
EPS (Basic)	-3.63	-16.26	-12.74	-	-	-
EPS (Diluted)	-3.63	-16.26	-12.74	-	-	-
Free Cash Flow	-54.12	-40.96	-29.73	-14.58	-	-
Free Cash Flow Per Share	-3.67	-15.55	-11.77	-	-	-
Gross Margin	-	-	-	-	100.00%	100.00%
EBITDA	-51.89	-43.17	-31.82	-15.25	-	-
D&A For EBITDA	1.51	1.48	1.01	0.36	-	-
EBIT	-53.4	-44.65	-32.83	-15.61	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.